Employers are starting to pull back on GLP-1 coverage for weight management—even as they keep covering the drugs for diabetes,, creating a new friction point for drugmakers and marketers. Employer coverage for weight loss fell from 72% in 2025 to 60% in 2026.
adweek.it
Cutbacks in GLP-1 Insurance Coverage Are Forcing Marketers to Pivot
Employer health costs are projected to spike in the upcoming year, forcing many companies that recently expanded coverage of GLP-1 drugs to reverse course.